IP Library Granted Patent US 8,342,182
Granted Patent B2
US 8,342,182 · App. 11/845,296 · Granted Jan 1, 2013

Functional assessment and treatment catheters and methods for their use in the lung

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,342,182
App. No.
11/845,296
Granted
Jan 1, 2013
Kind
B2
Abstract

Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed.

Claims (5)

1. A method for treating a target lung compartment, said method comprising: inserting a catheter having a detachable flow restrictive component connected thereto into the target lung compartment; deploying the detachable flow restrictive component while remaining connected to the catheter in an airway feeding the target lung compartment, whereby the target lung compartment is isolated and a flow path is created between a lumen in the shaft and a passage, lumen, or open interior within the detachable flow restrictive component which permits gas exchange between the lumen in the shaft and a distal region of the detachable flow restrictive component; determining whether collateral ventilation exists in the target lung compartment while the detachable flow restrictive element remains deployed in the airway; and detaching the detachable flow restrictive component from the catheter to leave said component in place in the airway if no significant collateral ventilation present; and contracting the detachable flow restrictive component and removing the catheter together with the detachable flow restrictive component if significant collateral ventilation is determined to be present.

2. A method as in claim 1 , wherein determining whether collateral ventilation exists comprises allowing gas flow via the flow path to or from the isolated target lung compartment through the catheter and flow restrictive component.

3. A method as in claim 2 , wherein determining collateral ventilation comprises detecting air flow or accumulation via the flow path from the isolated lung compartment through the catheter and flow restrictive component over time.

4. A method as in claim 1 , wherein the flow restrictive component allows a restrictive flow of air into and out of the isolated lung compartment after said component has been detached from the catheter.

5. A method as in claim 1 , wherein the flow restrictive element fully occludes the flow of air into and out of the isolated lung compartment after said component has been detached from the catheter.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2010
From: ALJURI, NIKOLAI
To: PULMONX
Reel/Frame 023843/0309 →